Paul Harrison
Family Medicine · Arlington, TXNPI 1780811158
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (49.4%), speaking fees and consulting fees — rather than concentrated in one kind of arrangement. 28 manufacturers reported payments, led by Teladoc Health, Inc. at 29.6% of the total. Among family medicine clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 247 payments — averaging $29.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Teladoc Health, Inc.$2K
- Biohaven Pharmaceutical Holding Company Ltd.$2K
- Novo Nordisk$584
- AbbVie$526
- Lilly USA, LLC$463
- AstraZeneca$217
- plus $2K from 22 others
What the payments were for
- Consulting fees$1,60022%
- Speaking & faculty fees$1,75024%
- Travel & lodging$3285%
- Food & beverage$3,59249%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Teladoc Health, Inc. | 4 | $2,150 |
| Biohaven Pharmaceutical Holding Company Ltd. | 15 | $1,784 |
| Novo Nordisk | 39 | $584 |
| AbbVie(2 entities) | 33 | $526 |
| Lilly USA, LLC | 51 | $463 |
| AstraZeneca | 7 | $217 |
| Merck | 18 | $214 |
| Pfizer | 11 | $179 |
| Boehringer Ingelheim | 10 | $158 |
| Sanofi-aventis U.S. LLC | 9 | $141 |
| Amgen | 5 | $94 |
| Biohaven Pharmaceuticals, Inc. | 6 | $93 |
| Medtronic | 1 | $90 |
| Abbott | 4 | $89 |
| Adlon Therapeutics L.p. | 3 | $64 |
| Johnson & Johnson | 4 | $60 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $58 |
| Sanofi Pasteur Inc. | 3 | $47 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $43 |
| GSK | 3 | $42 |
| Kowa Pharmaceuticals America, Inc. | 3 | $39 |
| Novartis | 2 | $31 |
| Currax Pharmaceuticals LLC | 2 | $28 |
| Upsher-smith Laboratories LLC | 1 | $19 |
| Nestle Healthcare Nutrition Inc. | 1 | $16 |
| IBSA Pharma Inc. | 1 | $16 |
| Aytu Biopharma, Inc. | 1 | $15 |
| Vivus LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NURTEC ODT$1,504
- FASENRA$124
- UBRELVY$113
How this compares
$7,271 in reported general payments places this provider in the 90th percentile of 8,760 family medicine providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 15 | $122 |
| Fluticasone Propionate | 15 | $112 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Arlington
- Bradley WassonArlington$734K
- Gilbert LedesmaArlington$34K
- Carlos CamposNew Braunfels$1.5M
- Aaron KingSan Antonio$1.1M
- Cynthia BrinsonAustin$402K
- Michael MendezLubbock$368K
- Sang Tae KimAmarillo$368K
- Sumit PerakathuHarlingen$342K
- Joel SolisMcAllen$324K
- Robert CampbellFort Worth$318K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.